Literature DB >> 10479477

Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network.

M E Higgins1, J P Davies, F W Chen, Y A Ioannou.   

Abstract

Niemann-Pick type C (NPC) disease is a severe cell lipidosis characterized by the accumulation of unesterified cholesterol in the endosomal/lysosomal system. Recently the primary disease-causing gene, NPC1, was identified, but few clues regarding its potential function(s) could be derived from its predicted amino acid sequence. Therefore, efforts were directed at characterizing the subcellular location of the NPC1 protein. Initial studies with a FLAG-tagged NPC1 cDNA demonstrated that NPC1 is a glycoprotein that associates with the membranes of a population of cytoplasmic vesicles. Immunofluorescence microscopy using anti-NPC1 polyclonal antibodies confirmed this analysis. Double-label immunofluorescence microscopy and subcellular fractionation studies indicated that NPC1 associates predominantly with late endosomes (Rab9 GTPase-positive vesicles) and, to a lesser extent, with lysosomes and the trans-Golgi network. When cholesterol egress from lysosomes was blocked by treatment of cells with U18666A, the NPC1 location shifted from late endosomes to the trans-Golgi network and lysosomes. Subcellular fractionation of liver homogenates from U18666A-treated mice confirmed these observations. These data suggest that U18666A may inhibit the retrograde transport of NPC1 from lysosomes to late endosomes for subsequent transfer to the trans-Golgi network. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10479477     DOI: 10.1006/mgme.1999.2882

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  87 in total

1.  Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop.

Authors:  G Millat; C Marçais; C Tomasetto; K Chikh; A H Fensom; K Harzer; D A Wenger; K Ohno; M T Vanier
Journal:  Am J Hum Genet       Date:  2001-05-01       Impact factor: 11.025

2.  Interactions of Npc1 and amyloid accumulation/deposition in the APP/PS1 mouse model of Alzheimer's.

Authors:  Ivan A Borbon; Robert P Erickson
Journal:  J Appl Genet       Date:  2010-12-18       Impact factor: 3.240

3.  Subviral Hepatitis B Virus Filaments, like Infectious Viral Particles, Are Released via Multivesicular Bodies.

Authors:  Bingfu Jiang; Kiyoshi Himmelsbach; Huimei Ren; Klaus Boller; Eberhard Hildt
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

Review 4.  The role of vesicular transport in ABCA1-dependent lipid efflux and its connection with NPC pathways.

Authors:  Emmanuel Boadu; Gordon A Francis
Journal:  J Mol Med (Berl)       Date:  2005-11-17       Impact factor: 4.599

5.  The organelle proteome of the DT40 lymphocyte cell line.

Authors:  Stephanie L Hall; Svenja Hester; Julian L Griffin; Kathryn S Lilley; Antony P Jackson
Journal:  Mol Cell Proteomics       Date:  2009-01-30       Impact factor: 5.911

6.  A Tissue- and Temporal-Specific Autophagic Switch Controls Drosophila Pre-metamorphic Nutritional Checkpoints.

Authors:  Xueyang Pan; Thomas P Neufeld; Michael B O'Connor
Journal:  Curr Biol       Date:  2019-08-15       Impact factor: 10.834

7.  Late endocytic multivesicular bodies intersect the chlamydial inclusion in the absence of CD63.

Authors:  Wandy L Beatty
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

Review 8.  Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking.

Authors:  Judith Storch; Zhi Xu
Journal:  Biochim Biophys Acta       Date:  2009-02-13

9.  Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis.

Authors:  Chris D Pacheco; Matthew J Elrick; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2008-12-12       Impact factor: 6.150

Review 10.  Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes.

Authors:  Richard J Cenedella
Journal:  Lipids       Date:  2009-05-14       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.